Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett-Mayer

Cancer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer|December 25, 2019
Geographically distributed data should be analyzed with spatial epidemiologic methodsElizabeth Garrett-Mayer
Cancer|February 28, 2017
Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancerEvan M Graboyes, Elizabeth Garrett-Mayer, Anand K Sharma, et al.
Cancer|February 10, 2017
Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data BaseEvan M Graboyes, Kevin Y Zhan, Elizabeth Garrett-Mayer, et al.
Cancer|July 14, 2007
Risks and benefits associated with novel phase 1 oncology trial designsShlomo A Koyfman, Manish Agrawal, Elizabeth Garrett-Mayer, et al.
Cancer|August 26, 2017
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancerEvan M Graboyes, Elizabeth Garrett-Mayer, Mark A Ellis, et al.
Cancer|April 2, 2009
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcomaDavid M Loeb, Elizabeth Garrett-Mayer, Robert F Hobbs, et al.
Cancer|March 15, 2023
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology RegistryDax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, et al.
Cancer|April 20, 2022
Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient surveyJennifer A Ligibel, Lori J Pierce, Catherine M Bender, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer|December 25, 2019
Geographically distributed data should be analyzed with spatial epidemiologic methodsElizabeth Garrett-Mayer
Cancer|February 28, 2017
Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancerEvan M Graboyes, Elizabeth Garrett-Mayer, Anand K Sharma, et al.
Cancer|February 10, 2017
Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data BaseEvan M Graboyes, Kevin Y Zhan, Elizabeth Garrett-Mayer, et al.
Cancer|July 14, 2007
Risks and benefits associated with novel phase 1 oncology trial designsShlomo A Koyfman, Manish Agrawal, Elizabeth Garrett-Mayer, et al.
Cancer|August 26, 2017
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancerEvan M Graboyes, Elizabeth Garrett-Mayer, Mark A Ellis, et al.
Cancer|April 2, 2009
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcomaDavid M Loeb, Elizabeth Garrett-Mayer, Robert F Hobbs, et al.
Cancer|March 15, 2023
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology RegistryDax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, et al.
Cancer|April 20, 2022
Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient surveyJennifer A Ligibel, Lori J Pierce, Catherine M Bender, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Pageof 1